Description: Cello Health plc, together with its subsidiaries, provides marketing services in the United Kingdom, the rest of Europe, the United States, and internationally. It operates in two segments, Cello Health and Cello Signal. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients. The Cello Signal segment provides market research and direct communications services principally to consumer-facing clients. Cello Health plc was incorporated in 2004 and is based in London, the United Kingdom.
Home Page: www.cellohealthplc.com
Officers
| Name | Title |
|---|---|
| Mr. Mark Scott | CEO & Exec. Director |
| Mr. Mark Bentley | Group Fin. Director & Exec. Director |
| Mr. Stephen Highley | Group COO & Director |
| Ms. Julia Anne Ralston | Exec. Director |
| Mr. Owen Williams | Managing Partner |
Exchange: OTCGREY
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 916 |